Compare MICC & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MICC | CRL |
|---|---|---|
| Founded | 2025 | 1947 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Specialty Foods | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.1B | 10.8B |
| IPO Year | 2025 | 1999 |
| Metric | MICC | CRL |
|---|---|---|
| Price | $18.93 | $272.26 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 12 |
| Target Price | N/A | ★ $198.27 |
| AVG Volume (30 Days) | 786.8K | ★ 789.8K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,857,601,000.00 |
| Revenue This Year | $5.51 | N/A |
| Revenue Next Year | $4.17 | $3.04 |
| P/E Ratio | $28.55 | ★ N/A |
| Revenue Growth | N/A | ★ 10.48 |
| 52 Week Low | $12.94 | $144.26 |
| 52 Week High | $20.69 | $303.31 |
| Indicator | MICC | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 46.11 | 47.11 |
| Support Level | $18.88 | $215.89 |
| Resistance Level | $20.02 | $303.31 |
| Average True Range (ATR) | 0.39 | 7.43 |
| MACD | -0.11 | -4.30 |
| Stochastic Oscillator | 7.10 | 15.57 |
The Magnum Ice Cream Company is a spinoff from Unilever, a pure-play company in manufacturing and selling a broad portfolio of ice-cream brands. The company is a global category leader, operating in 80 countries with around 21% market share. TMICC owns four of the world's five largest ice-cream brands: the Heartbrand (an "umbrella" brand with numerous well-known subbrands, which constitutes around 35% of sales), Magnum (23%), Ben & Jerry's (14%), and Cornetto (9%). The business generates about 65% of its revenue in developed markets, with the balance coming from emerging markets.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.